Le Lézard
Classified in: Business
Subject: LAW

Hearing Notice - CIRO to Hold a Disciplinary Hearing for Lorne Allison


VANCOUVER, BC, April 19, 2024 /CNW/ - A hearing has been scheduled before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) under the Mutual Fund Dealer Rules in the matter of Lorne Stuart Allison.

The hearing is open to the public unless the panel orders otherwise. The decision of the hearing panel will be made available at www.ciro.ca.   

Hearing Date:                              October 17, 2024, at 10:00 am (Pacific Time)

Location:                                      Vancouver, British Columbia by videoconference

Members of the public who would like to obtain further particulars should fill out this questionnaire.

The hearing concerns allegations that between September 2020 and February 2021, Lorne Allison engaged in securities related business that was not carried on for the account or through the facilities of the Dealer Member.

The Notice of Hearing and Statement of Allegations, which set out the allegations, are available at:

Allison, Lorne ? Notice of Hearing and Statement of Allegations  

At all material times, Lorne Allison carried on business in the Vancouver Island, British Columbia area. Lorne Allison is not currently registered in the securities industry in any capacity.

All information about disciplinary proceedings relating to current and former member firms and individual registrants under the Investment Dealer and Partially Consolidated Rules (for investment dealers), the Mutual Fund Dealer Rules (for mutual fund dealers) and the Universal Market Integrity Rules (UMIR) is available on CIRO's website

Background information regarding the qualifications and disciplinary history, if any, of advisors currently employed by CIRO-regulated investment firms is available free of charge through the AdvisorReport service. Information on how to make dealer, advisor or marketplace-related complaints is available by calling 1-877-442-4322.

CIRO investigates possible misconduct by its member firms and individual registrants. It can bring disciplinary proceedings which may result in sanctions including fines, suspensions, permanent bars, expulsion from membership, or termination of rights and privileges for individuals and firms.

The Canadian Investment Regulatory Organization (CIRO) is the national self-regulatory organization that oversees all investment dealers, mutual fund dealers and trading activity on Canada's debt and equity marketplaces. CIRO is committed to the protection of investors, providing efficient and consistent regulation, and building Canadians' trust in financial regulation and the people managing their investments. For more information, visit www.ciro.ca.

SOURCE Canadian Investment Regulatory Organization (CIRO)


These press releases may also interest you

at 16:10
Floor & Decor Holdings, Inc. ("We," "Our," the "Company," or "Floor & Decor") announces its financial results for the first quarter of fiscal 2024, which ended March 28, 2024. Tom Taylor, Chief Executive Officer, stated, "We are pleased to report...

at 16:10
ACCO Brands Corporation today reported financial results for the first quarter ended March 31, 2024. "Our first quarter results demonstrate our commitment to improving profitability and cash flow generation as we work to overcome persistent...

at 16:10
Tandem Diabetes Care, Inc. , a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2024 and increased sales guidance for the year ending December 31, 2024. First Quarter 2024...

at 16:10
Grid Dynamics Holdings, Inc. ("Grid Dynamics" or "Company"), a leader in enterprise-level digital transformation, today announced results for the first quarter ended March 31, 2024. We are very pleased to report the first quarter 2024 revenues of...

at 16:10
Five9, Inc. , the Intelligent CX Platform provider, today reported results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Revenue for the first quarter of 2024 increased 13% to a record $247.0 million, compared...

at 16:10
Puma Biotechnology, Inc. , a biopharmaceutical company, announced financial results for the first quarter ended March 31, 2024. Unless otherwise stated, all comparisons are for the first quarter 2024 compared to the first quarter 2023. Product...



News published on and distributed by: